Archive

Archive for the ‘Earnings Report Card’ Category

Advanced Cell Technology (OTCBB: ACTC) Q1/13 Results, how many shares doesn’t it take to light a beacon – 2.39 billion?

May 17th, 2013 No comments

ACTC      Net loss of $6.4 M or $0.00 per share Read more…

Neuralstem (NYSE MKT: CUR) Q1/13 Results – SELL – can’t argue with recent appreciation but how long will it last?

May 17th, 2013 No comments

neuralstem  Net loss of approximately $3.59 M or $0.05 per share Read more…

International Stem Cell (OTC: ISCO) – HOLD – going where, when and how?

May 16th, 2013 No comments

isco.ob              Net loss was $1.7 M or $0.02 per share Read more…

ThermoGenesis (KOOL) Q3/13 Results – HOLD – based on capacities, capabilities, revenue, competition and trials – otherwise KOOL will “drip” downward as 2013 “floats”!

May 16th, 2013 No comments

thermogenesis_112x112                     Net loss was $1.1 M or $0.07 per share Read more…

Tengion (OTC: TNGN) Q1/13 Results – HOLD, waiting for Godot

May 15th, 2013 No comments

l_Tengion      Net loss was $5 million or $2.09 per share Read more…

Athersys (ATHX) Q1/13 Results – SELL until it settles and then re-enter!

May 15th, 2013 No comments

athersys      Net loss for of $9.4 million or $0.18 per share Read more…

Opexa Therapeutics (OPXA) Q1/13 Results – SELL and then wait until it settles to re-enter!

May 14th, 2013 No comments

opexa    Net loss of $4.1 million or $0.58 per share Read more…

BioLife Solutions (OTCQB: BLFS), Q1/13 Results – BUY

May 14th, 2013 No comments

biolife solutions    Net loss was $7.2 K, or $0.00 per share Read more…

BioTime (NYSE MKT: BTX) Q1/13 Results – BUY, returning the share price in the short-term future

May 13th, 2013 No comments

BioTime_Logo      Net loss of 7.7 million, or $0.15 per share Read more…

Dendreon (DNDN) Q1/13 Results, Pricing the therapy is still the “electronic” collar on this dog’s neck – SELL

May 10th, 2013 No comments

dendreon-logo    Net loss of $72 million, or $0.48 per share Read more…